NCT04323956 2026-02-02Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell LymphomaMayo ClinicPhase 1 Active not recruiting50 enrolled
NCT04195945 2025-07-10CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit PatientsFred Hutchinson Cancer CenterPhase 2 Active not recruiting60 enrolled